Teclistamab in Relapsed or Refractory Multiple Myeloma Journal Articles

authors

• Cliff, Edward R Scheffer
• Mian, Hira
• Mohyuddin, Ghulam Rehman

status

• published 

publication date

• November 3, 2022

has subject area

• 11 Medical and Health Sciences (FoR)
• Antibodies, Bispecific (MeSH)
• Antineoplastic Agents (MeSH)
• Antineoplastic Combined Chemotherapy Protocols (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Multiple Myeloma (MeSH)
• Neoplasm Recurrence, Local (MeSH)

published in

• New England Journal of Medicine  Journal

keywords

• Antibodies, Bispecific
• Antineoplastic Agents
• Antineoplastic Combined Chemotherapy Protocols
• Humans
• Multiple Myeloma
• Neoplasm Recurrence, Local

Digital Object Identifier (DOI)

• 10.1056/nejmc2211969

PubMed ID

• 36322861

start page

• 1721

end page

• 1723

volume

• 387

issue

• 18